GI360 Stool Test by Doctor's Data

The GI360™ Profile is an innovative, comprehensive and clinically-applicable stool profile, utilizing multiplex PCR molecular technology coupled with growth-based culture and ID by MALDI-TOF, sensitive biochemical assays and microscopy to detect and assess the status of pathogens, viruses, parasites and bacteria that may be contributing to acute or chronic gastrointestinal symptoms and disease. Microbiome Abundance and Diversity The GI360™ Profile is a gut microbiota DNA analysis tool that identifies and characterizes the abundance and diversity of more than 45 targeted analytes that peer-reviewed research has shown to contribute to dysbiosis and other chronic disease states. The GI360™ can identify the presence of pathogenic viruses, bacteria, and parasites using multiplexed, real-time PCR. Viruses are the primary cause of acute diarrhea, and the least commonly tested. The identification of pathogenic bacteria, viruses and parasites improves treatment strategies and patient outcomes. The Dysbiosis Index (DI) is a calculation with scores from 1 to 5 based on the overall bacterial abundance and profile within the patient's sample as compared to a reference population. Values above 2 indicate a microbiota profile that differs from the defined normobiotic reference population (i.e., dysbiosis). The higher the DI above 2, the more the sample is considered to deviate from normobiosis.

The GI360 Stool Test by Doctor's Data is a comprehensive and innovative stool profile designed to detect and assess the status of pathogens, viruses, parasites, and bacteria that may be contributing to acute or chronic gastrointestinal symptoms and disease. The test utilizes multiplex PCR molecular technology, coupled with growth-based culture and ID by MALDI-TOF, sensitive biochemical assays, and microscopy to provide accurate and clinically applicable results.

One of the key features of the GI360™ Stool Test is Microbiome Abundance and Diversity analysis, which is a gut microbiota DNA analysis tool that identifies and characterizes the abundance and diversity of more than 45 targeted analytes that have been shown to contribute to dysbiosis and other chronic disease states.

The test can identify the presence of pathogenic viruses, bacteria, and parasites using multiplexed, real-time PCR. This is important as viruses are the primary cause of acute diarrhea and are the least commonly tested. The identification of pathogenic bacteria, viruses, and parasites can improve treatment strategies and patient outcomes.

Another important feature of the GI360™ Stool Test is the Dysbiosis Index (DI), which is a calculation with scores from 1 to 5 based on the overall bacterial abundance and profile within the patient's sample compared to a reference population. Values above 2 indicate a microbiota profile that differs from the defined normobiotic reference population (i.e., dysbiosis). The higher the DI above 2, the more the sample is considered to deviate from normobiosis.

Overall, the GI360™ Stool Test is a comprehensive and clinically applicable stool profile that provides valuable information to help diagnose and treat gastrointestinal symptoms and disease. The test utilizes advanced technology and analysis to provide accurate and clinically applicable results for patients.